Overview of changes in the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing: M100 32nd and 33rd editions. / Audrey N Schuetz; Andrea Ferrell; Janet A Hindler [and others].

By: Contributor(s): Material type: ArticleLanguage: English Publisher: [Place of publication not identified] : American Society for Microbiology (ASM), 2025Description: 1 online resource (1 article)Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
Subject(s): Genre/Form: In: Journal of clinical microbiology Vol. 63, no. 9, (2025), pages/article e0162323Abstract: The Clinical and Laboratory Standards Institute Subcommittee on Antimicrobial Susceptibility Testing (AST) publishes annual updates to the M100 Performance Standards for Antimicrobial Susceptibility Testing . This important document contains key information critical to the laboratory's performance of accurate and current AST. This minireview will highlight and provide supporting data for major changes in the M100 32nd and 33rd editions published in February 2022 and March 2023, respectively. New and revised breakpoints for gram-negative and gram-positive organisms are explained. Proper use of the restructured M100 Table 1 guidance for antimicrobial agents to be considered for testing and reporting is outlined. Reporting guidance for multidrug-resistant gram-negative bacilli is discussed. Other topics within this minireview include additional agents to test and report for direct blood disk diffusion of gram-negative bacilli and quality control range changes and troubleshooting. The minireview concludes with other issues under consideration by the AST Subcommittee.
List(s) this item appears in: Open Access Resources
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication type: Review article.

Linked open-access copy: published version.

Open access; no subscription required for the linked open-access version. Unrestricted online access star

The Clinical and Laboratory Standards Institute Subcommittee on Antimicrobial Susceptibility Testing (AST) publishes annual updates to the M100 Performance Standards for Antimicrobial Susceptibility Testing . This important document contains key information critical to the laboratory's performance of accurate and current AST. This minireview will highlight and provide supporting data for major changes in the M100 32nd and 33rd editions published in February 2022 and March 2023, respectively. New and revised breakpoints for gram-negative and gram-positive organisms are explained. Proper use of the restructured M100 Table 1 guidance for antimicrobial agents to be considered for testing and reporting is outlined. Reporting guidance for multidrug-resistant gram-negative bacilli is discussed. Other topics within this minireview include additional agents to test and report for direct blood disk diffusion of gram-negative bacilli and quality control range changes and troubleshooting. The minireview concludes with other issues under consideration by the AST Subcommittee.

Creative Commons Attribution. See the linked licence for the applicable terms.

https://creativecommons.org/licenses/by/4.0/

In English.

Description generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source.

Course allocation: B. Sc. Medical Laboratory Science.

There are no comments on this title.

to post a comment.